We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
84 hedge funds and large institutions have $398M invested in Esperion Therapeutics in 2014 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 28 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,167% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 3
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
193% more capital invested
Capital invested by funds: $136M → $398M (+$262M)
133% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 12
68% more funds holding
Funds holding: 50 → 84 (+34)
23% more call options, than puts
Call options by funds: $2.82M | Put options by funds: $2.29M
Holders
84
Holders Change
+34
Holders Change %
+68%
% of All Funds
2.24%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
38
Increased
28
Reduced
12
Closed
3
Calls
$2.82M
Puts
$2.29M
Net Calls
+$529K
Net Calls Change
+$529K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$40.3M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
+$16.2M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$14.7M |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$12.8M |
| 5 |
PA
Perceptive Advisors
New York
|
+$9.26M |
Top Sellers
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$4.02M |
| 2 |
Millennium Management
New York
|
-$2.03M |
| 3 |
Morgan Stanley
New York
|
-$1.32M |
| 4 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$1.07M |
| 5 |
Jane Street
New York
|
-$1,000K |
